天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

GM-CSF蛋白,GM-CSF
  • GM-CSF蛋白,GM-CSF
  • GM-CSF蛋白,GM-CSF
  • GM-CSF蛋白,GM-CSF

重組人GM-CSF蛋白-ACROBiosystems百普賽斯

價(jià)格 詢(xún)價(jià)
包裝 100ug 500ug 1000ug
最小起訂量 100ug
發(fā)貨地 北京
更新日期 2024-12-16
微信洽談

產(chǎn)品詳情

中文名稱(chēng):GM-CSF蛋白英文名稱(chēng):GM-CSF
CAS:99283-10-0品牌: 百普賽斯
產(chǎn)地: 北京保存條件: -20°C to -70°C
純度規(guī)格: 99.9%產(chǎn)品類(lèi)別: 重組蛋白
貨號(hào): GM-CSF用途范圍: 藥物開(kāi)發(fā)等
規(guī)格: 100ug是否進(jìn)口:
2024-12-16 GM-CSF蛋白 GM-CSF 100ug/RMB;500ug/RMB;1000ug/RMB 百普賽斯 北京 -20°C to -70°C 99.9% 重組蛋白

Human GM-CSF Protein, premium grade

分子別名(Synonym

GM-CSF,CSF2,MGC131935

表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source

Human GM-CSF, premium grade (GMF-H4214) is expressed from human 293 cells (HEK293). It contains AA Ala 18 - Glu 144 (Accession # NP_000749.2).

Predicted N-terminus: Ala 18

It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage. When ready to transition into later clinical phases, we also offer a custom GMP protein service that tailors to your needs. We will work with you to customize and develop a GMP-grade product in accordance with your requests that also meets the requirements for raw and ancillary materials use in cell manufacturing of cell-based therapies.

蛋白結(jié)構(gòu)(Molecular Characterization

1.jpg

This protein carries no "tag".

The protein has a calculated MW of 14.5 kDa. The protein migrates as 25 kDa±3 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

內(nèi)毒素(Endotoxin

Less than 0.01 EU per μg by the LAL method.

宿主蛋白殘留(Host Cell Protein

<0.5 ng/μg of protein tested by ELISA.

宿主核酸殘留(Host Cell DNA

<0.02 ng/μg of protein tested by qPCR.

無(wú)菌(Sterility

Negative

支原體(Mycoplasma

Negative.

純度(Purity

>95% as determined by SDS-PAGE.

>95% as determined by SEC-MALS.

制劑(Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

重構(gòu)方法(Reconstitution

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

存儲(chǔ)(Storage

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

-20°C to -70°C for 24 months in lyophilized state;

-70°C for 3 months under sterile conditions after reconstitution.

2.jpg

3.jpg

背景(Background

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is also known as Colony stimulating factor 2 (granulocyte-macrophage), is a cytokine initially characterized by its ability to induce colonies of granulocytes and macrophages from myeloid progenitor cells, and is secreted by macrophages, T cells, mast cells, endothelial cells and fibroblasts. GM-CSF is a cytokine that functions as a white blood cell growth factor. GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes. Monocytes exitthe circulation and migrate into tissue, whereupon they mature into macrophages and dendritic cells. Thus, it is part of the immune/inflammatory cascade, by which activation of a small number of macrophages can rapidly lead to an increase in their numbers, a process crucial for fighting infection. The active form of the protein is found extracellularly as a homodimer. Human GM-CSF glycosylated in its mature form. As a part of the immune/inflammatory cascade, GM-CSF promotes Th1 biased immune response, angiogenesis, allergic inflammation, and the development of autoimmunity, and thus worthy of consideration for therapeutic target. GM-CSF has also recently been evaluated in clinical trials for its potential as a vaccine adjuvant in HIV-infected patients. The preliminary results have been promising. GM-CSF is also used as a medication to stimulate the production of white blood cells following chemotherapy.

關(guān)鍵字: GM-CSF;GM-CSF蛋白;GM-CSF重組蛋白;ACRO;百普賽斯;

公司簡(jiǎn)介

百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶(hù)超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。
成立日期 2010-07-22 (15年) 注冊(cè)資本 8000萬(wàn)人民幣
員工人數(shù) 500人以上 年?duì)I業(yè)額 ¥ 1億以上
主營(yíng)行業(yè) 醫(yī)藥中間體,原料藥,激素類(lèi),氨基糖苷類(lèi),中樞神經(jīng)系統(tǒng)用藥 經(jīng)營(yíng)模式 工廠,試劑
  • 北京百普賽斯生物科技股份有限公司
VIP 2年
  • 公司成立:15年
  • 注冊(cè)資本:8000萬(wàn)人民幣
  • 企業(yè)類(lèi)型:其他股份有限公司(上市)
  • 主營(yíng)產(chǎn)品:重組蛋白,抗原,抗體,試劑盒
  • 公司地址:北京市北京經(jīng)濟(jì)技術(shù)開(kāi)發(fā)區(qū)宏達(dá)北路8號(hào)4幢4層
詢(xún)盤(pán)

重組人GM-CSF蛋白-ACROBiosystems百普賽斯相關(guān)廠家報(bào)價(jià)

產(chǎn)品名稱(chēng) 價(jià)格   公司名稱(chēng) 報(bào)價(jià)日期
¥646
VIP6年
上??道噬锟萍加邢薰?/div>
2024-12-27
詢(xún)價(jià)
VIP8年
成都云希化工有限公司
2024-12-27
詢(xún)價(jià)
碧云天生物技術(shù)有限公司
2024-12-25
詢(xún)價(jià)
碧云天生物技術(shù)有限公司
2024-12-25
詢(xún)價(jià)
碧云天生物技術(shù)有限公司
2024-12-25
詢(xún)價(jià)
碧云天生物技術(shù)有限公司
2024-12-25
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價(jià)格指該商品的參考價(jià)格,并非原價(jià),該價(jià)格可能隨著市場(chǎng)變化,或是由于您購(gòu)買(mǎi)數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價(jià)格,請(qǐng)咨詢(xún)商家,以實(shí)際成交價(jià)格為準(zhǔn)。請(qǐng)意識(shí)到互聯(lián)網(wǎng)交易中的風(fēng)險(xiǎn)是客觀存在的